Loading cancer entity…
Loading cancer entity…
Clinical trials
10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03525834 | Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex. | completed | Phase 4 | 40 | Novartis PharmaceuticalsINDUSTRY | 1 | Sep 9, 2021 | clinicaltrials |
| NCT01217125 | Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis | completed | Phase 4 | 18 | Fundacio PuigvertOTHER | 0 | Mar 8, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Sep 9, 2021source: clinicaltrials